The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Long-Term Risk of Cardiovascular Disease in 5-Year Survivors of Testicular Cancer
Open accessAbstract
Purpose: To evaluate the long-term risk of cardiovascular disease (CVD) in survivors of testicular cancer (TC). Patients and Methods: We compared CVD incidence in 2,512 5-year survivors of TC, who were treated between 1965 and 1995, with general population rates. Treatment effects on CVD risk were quantified in multivariate Cox regression analysis. Results: After a median follow-up of 18.4 years, 694 cardiovascular events occurred, including 141 acute myocardial infarctions (MIs). The standardized incidence ratio (SIR) for coronary heart disease was 1.17 (95% CI, 1.04 to 1.31), with 14 excess cases per 10,000 person-years. The SIR for MI was significantly increased in nonseminoma survivors with attained ages of less than 45 (SIR = 2.06) and 45 to 54 years (SIR = 1.86) but significantly decreased for survivors with attained ages of 55 years or older (SIR = 0.53). In Cox analysis, mediastinal irradiation was associated with a 3.7-fold (95% CI, 2.2- to 6.2-fold) increased MI risk compared with surgery alone, whereas infradiaphragmatic irradiation was not associated with an increased MI risk. Cisplatin, vinblastine, and bleomycin (PVB) chemotherapy (CT) was associated with a 1.9-fold (95% CI, 1.7- to 2.0-fold) increased MI risk, and bleomycin, etoposide, and cisplatin (BEP) CT was associated with a 1.5-fold (95% CI, 1.0- to 2.2-fold) increased CVD risk and was not associated with increased MI risk (hazard ratio = 1.2; 95% CI, 0.7 to 2.1). Recent smoking was associated with a 2.6-fold (95% CI, 1.8- to 3.9-fold) increased MI risk. Conclusion: Nonseminomatous TC survivors experience a moderately increased MI risk at young ages. Physicians should be aware of excess CVD risk associated with mediastinal radiotherapy, PVB CT, and recent smoking. Intervention in modifiable cardiovascular risk factors is especially important in TC survivors. Whether BEP treatment increases CVD risk should be evaluated after more prolonged follow-up.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies
Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,592
Williams, S. D., Birch, R., Einhorn, L. H., Irwin, L., Greco, F. A., & Loehrer, P. J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162302 · Cited by 1,170
Cuzick, J., Stewart, H., Rutqvist, L., Houghton, J., Edwards, R., Redmond, C., Peto, R., Baum, M., Fisher, B., & Host, H. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.3.447 · Cited by 889
Factors Affecting Late Mortality From Heart Disease After Treatment of Hodgkin's Disease
Hancock, S. L. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510160067031 · Cited by 773
Cardiotoxicity of Chemotherapeutic Agents: Incidence, Treatment and Prevention
Pai, V. B., & Nahata, M. C. (2000) · Drug Safety · doi:10.2165/00002018-200022040-00002 · Cited by 729
Cardiovascular Disease as a Long-Term Complication of Treatment for Testicular Cancer
Huddart, R. A., Norman, A., Shahidi, M., Horwich, A., Coward, D., Nicholls, J., & Dearnaley, D. P. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.173 · Cited by 547
山口, 博. (2006) · Mebio oncology · Cited by 516
Cardiovascular Morbidity in Long-Term Survivors of Metastatic Testicular Cancer
Meinardi, M. T., Gietema, J. A., van der Graaf, W. T. A., van Veldhuisen, D. J., Runne, M. A., Sluiter, W. J., de Vries, E. G. E., Willemse, P. B. H., Mulder, N. H., van den Berg, M. P., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.8.1725 · Cited by 489
Self-citationRisk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer
Travis, L. B., Curtis, R. E., Fraumeni, J. F., Boice, J. D., Storm, H., Andersson, M., Hall, P., Bergfeldt, K., Holowaty, E., Clarke, E. A., et al. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.19.1429 · Cited by 488
Self-citationEffects of Combined Drug Therapy on Metastatic Cancer of the Testis
Li, M. C., WHITMORE, W. F., GOLBEY, R., & GRABSTALD, H. (1960) · JAMA · doi:10.1001/jama.1960.03030100059013 · Cited by 424
Rutqvist, L. E., Lax, I., Fornander, T., & Johansson, H. (1992) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(92)90784-f · Cited by 391
Einhorn, L. H. (1981) · PubMed · Cited by 338
Mortality After Cure of Testicular Seminoma
Zagars, G. K., Ballo, M. T., Lee, A. K., & Strom, S. S. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.205 · Cited by 286
Coronary artery disease mortality in patients treated for hodgkin's disease
Boivin, J., Hutchison, G. B., Lubin, J. H., & Mauch, P. (1992) · Cancer · doi:10.1002/cncr.2820690528 · Cited by 278
Evaluation of long-term toxicity after chemotherapy for testicular cancer.
Bokemeyer, C., Berger, C. C., Kuczyk, M. A., & Schmoll, H. J. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.11.2923 · Cited by 268
Second cancer risk following testicular cancer: a follow-up study of 1,909 patients.
van Leeuwen, F. E., Stiggelbout, A. M., van den Belt-Dusebout, A. W., Noyon, R., Eliel, M. R., van Kerkhoff, E. H., Delemarre, J. F., & Somers, R. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.415 · Cited by 250
Self-citationCOMBINED MANAGEMENT OF MALIGNANT TERATOMA OF THE TESTIS
Peckham, M. J., Barrett, A., Mcelwain, T. J., & Hendry, W. F. (1979) · The Lancet · doi:10.1016/s0140-6736(79)90288-5 · Cited by 246
Circulating plasma platinum more than 10 years after cisplatin treatment for testicular cancer
Gietema, J., Meinardi, M., Messerschmidt, J., Gelevert, T., Alt, F., Uges, D., & Th Sleijfer, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02044-4 · Cited by 216
Self-citationGonadal Hormones in Long-Term Survivors 10 Years after Treatment for Unilateral Testicular Cancer
Nord, C., Bjøro, T., Ellingsen, D., Mykletun, A., Dahl, O., Klepp, O., Bremnes, R. M., Wist, E., & Fosså, S. D. (2003) · European Urology · doi:10.1016/s0302-2838(03)00263-x · Cited by 197
Nuver, J., Smit, A. J., Wolffenbuttel, B. H. R., Sluiter, W. J., Hoekstra, H. J., Sleijfer, D. T., & Gietema, J. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.176 · Cited by 190
Self-citationJones, J. M., & Ribeiro, G. G. (1989) · Clinical Radiology · doi:10.1016/s0009-9260(89)80099-6 · Cited by 165
Nuver, J., Smit, A. J., Wolffenbuttel, B. H., Sluiter, W. J., Hoekstra, H. J., Sleijfer, D. T., & Gietema, J. A. (2006) · Journal of Urology · doi:10.1016/s0022-5347(05)01043-8 · Cited by 163
Self-citationNuver, J., Smit, A. J., Sleijfer, D. T., van Gessel, A. I., van Roon, A. M., van der Meer, J., van den Berg, M. P., Burgerhof, J. G. M., Hoekstra, H. J., Sluiter, W. J., et al. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.12.012 · Cited by 149
Self-citationIschemic heart disease after mantlefield irradiation for Hodgkin's disease in long-term follow-up
Reinders, J. G., Heijmen, B. J. M., Acht, M. J. J. O.-V., van Putten, W. L. J., & Levendag, P. C. (1999) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(99)00026-2 · Cited by 148
Increased mortality rates in young and middle-aged patients with malignant germ cell tumours
Fosså, S. D., Aass, N., Harvei, S., & Tretli, S. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601558 · Cited by 84
Stage I testicular seminoma: rationale for postorchiectomy radiation therapy
Zagars, G. K., & Babaian, R. J. (1987) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(87)90122-2 · Cited by 71
Endocrinological late effects after chemotherapy for testicular cancer
Berger, C. C., Bokemeyer, C., Schuppert, F., & Schmoll, H. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.213 · Cited by 60
Excessive annual BMI increase after chemotherapy among young survivors of testicular cancer
Nord, C., Fosså, S. D., & Egeland, T. A. M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600714 · Cited by 45
Clamon, G. H., Gardner, L. B., Pee, D., Stumbo, P., Feld, R. D., Evans, W. K., Weiner, R. S., Moran, E. M., Blum, R., Hoffman, F. A., et al. (1985) · Cancer · doi:10.1002/1097-0142(19850401)55:7<1612::aid-cncr2820550734>3.0.co;2-b · Cited by 10
Cited by
Stewart, F. A., Akleyev, A. V., Hauer-Jensen, M., Hendry, J. H., Kleiman, N. J., MacVittie, T. J., Aleman, B. M., Edgar, A. B., Mabuchi, K., Muirhead, C. R., et al. (2012) · Annals of the ICRP · doi:10.1016/j.icrp.2012.02.001 · Cited by 1,604
Self-citationCarver, J. R., Shapiro, C. L., Ng, A., Jacobs, L., Schwartz, C., Virgo, K. S., Hagerty, K. L., Somerfield, M. R., & Vaughn, D. J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.9777 · Cited by 793
Late cardiotoxicity after treatment for Hodgkin lymphoma
Aleman, B. M. P., van den Belt-Dusebout, A. W., De Bruin, M. L., van 't Veer, M. B., Baaijens, M. H. A., Boer, J. P. D., Hart, A. A. M., Klokman, W. J., Kuenen, M. A., Ouwens, G. M., et al. (2007) · Blood · doi:10.1182/blood-2006-07-034405 · Cited by 746
Self-citationKrege, S., Beyer, J., Souchon, R., Albers, P., Albrecht, W., Algaba, F., Bamberg, M., Bodrogi, I., Bokemeyer, C., Cavallin-Ståhl, E., et al. (2008) · European Urology · doi:10.1016/j.eururo.2007.12.024 · Cited by 617
Self-citationCardiovascular Disease After Hodgkin Lymphoma Treatment: 40-Year Disease Risk
van Nimwegen, F. A., Schaapveld, M., Janus, C. P. M., Krol, A. D. G., Petersen, E. J., Raemaekers, J. M. M., Kok, W. E. M., Aleman, B. M. P., & van Leeuwen, F. E. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.1180 · Cited by 514
Self-citation
Metadata
- Authors
- van den Belt-Dusebout, A. W., Nuver, J., de Wit, R., Gietema, J. A., ten Bokkel Huinink, W. W., Rodrigus, P. T. R., Schimmel, E. C., Aleman, B. M. P., & van Leeuwen, F. E.
- Venue
- Journal of Clinical Oncology
- Published
- 2006-01-20
- Volume
- 24
- Issue
- 3
- Pages
- 467-475
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2125784459
- Cited by
- 345
- References
- 35
- FWCI
- 15.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.